Precursor Cell Lymphoblastic Leukemia-Lymphoma: all 2,121 studies
Page 18 of 22. Open to participants first (492), then studies with results posted, then the rest; newest registration first within each.
- Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALLCompletedNCT01228331Phase 2/3
- Biomarkers to Classify Young Patients With Acute Lymphoblastic Leukemia (ALL) and Remission Induction Therapy in Young Patients With B-Precursor ALLCompletedNCT01225874Not applicable
- Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)SuspendedNCT01222013Phase 2
- Computerized Intervention for Amelioration of Cognitive Late Effects Among Childhood Cancer SurvivorsCompletedNCT01217996Not applicable
- AHN-12 Biodistribution in Advanced LeukemiaTerminatedNCT01207076Phase 1
- Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell TransplantNo longer availableNCT01200017
- Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell TransplantActive, not recruitingNCT01199562
- A Study of Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic LeukaemiaCompletedNCT01196013Phase 1
- CD19-CAR Immunotherapy for Childhood Acute Lymphoblastic Leukemia (ALL)TerminatedNCT01195480Phase 1/2
- Multicenter Clinical Trial for Adult Ph-negative ALL. Non-intensive But Non-iterruptive TreatmentStatus unknownNCT01193933Not applicable
- Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHLTerminatedNCT01187810Phase 1
- Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic LeukemiaStatus unknownNCT01185886
- Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related DisordersActive, not recruitingNCT01177527
- High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaCompletedNCT01177371Phase 2
- Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic MalignanciesCompletedNCT01175785Phase 2
- PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute LeukemiasCompletedNCT01169012Phase 1
- Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL)CompletedNCT01167166Phase 1/2
- T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic MalignanciesWithdrawnNCT01163201Phase 1/2
- Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic LeukemiaWithdrawnNCT01162031Phase 2
- Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDSCompletedNCT01159028Phase 1
- RO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsCompletedNCT01158274Phase 1
- Combination Chemotherapy in Treating Young Adult Patients With Acute Lymphoblastic LeukemiaCompletedNCT01156883Not applicable
- Lestaurtinib With or Without Chemotherapy Agents in Samples From Young Patients With LeukemiaCompletedNCT01150669
- Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced LeukemiasCompletedNCT01149915Phase 1
- Quality of Life Study for Adult Patients With Acute Lymphoblastic LeukemiaCompletedNCT01148927
- Pharmacokinetic Profile of Vincristine Administered With Imatinib for Bcr-Abl Positive Acute Lymphoblastic Leukemia (ALL) Compared to That Without Imatinib for Bcr-Abl Negative ALLTerminatedNCT01148134
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT01142427
- Veliparib and Temozolomide in Treating Patients With Acute LeukemiaCompletedNCT01139970Phase 1
- Carfilzomib in Patients With Relapsed Acute Myeloid or Acute Lymphoblastic LeukemiaCompletedNCT01137747Phase 1
- Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic LeukemiaCompletedNCT01132573Phase 1
- AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or LymphomaCompletedNCT01129193Phase 1
- Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic LeukemiaCompletedNCT01119586
- International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic LeukemiaCompletedNCT01117441Phase 3
- Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic LeukemiaCompletedNCT01116193Phase 2
- Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin LymphomaTerminatedNCT01116154Phase 1
- Prevention of Left Ventricular Dysfunction During ChemotherapyCompletedNCT01110824Phase 3
- ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic MalignanciesCompletedNCT01110473Phase 1
- Osteonecrosis in Children With Acute Lymphoblastic LeukemiaStatus unknownNCT01104324
- Pharmacokinetic Study of Doxorubicin in Children With CancerCompletedNCT01095926Phase 2
- Hemostasis During Asparaginase Treatment in Acute Lymphoblastic Leukemia(ALL)CompletedNCT01094392
- Genomic Changes in Childhood Acute Lymphoblastic LeukemiaStatus unknownNCT01089907
- Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaTerminatedNCT01088763Phase 1
- Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT01085617
- Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic LeukemiaStatus unknownNCT01079507
- T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric AnalysisCompletedNCT01078337
- Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic SyndromeCompletedNCT01075425Phase 1
- A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell TransplantationCompletedNCT01068301Phase 1
- Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.TerminatedNCT01066468Phase 1
- Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for CancerCompletedNCT01053494Not applicable
- Effect of Enteral Docosahexaenoic Acid Administration in Children With Acute Lymphoblastic LeukemiaCompletedNCT01051154Phase 2
- Safety Study of ON 013105 in Lymphoma and Acute Lymphoid LeukemiaTerminatedNCT01049113Phase 1
- Motor Proficiency And Physical Activity in Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)CompletedNCT01047020
- Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin LymphomaTerminatedNCT01045928Phase 1
- MSC and HSC Coinfusion in Mismatched MinitransplantsTerminatedNCT01045382Phase 2
- Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19Active, not recruitingNCT01044069Phase 1
- Donor-specific Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia (ALL)TerminatedNCT01037764Phase 2
- PR104 in Treating Patients With Refractory/Relapsed Acute LeukemiaStatus unknownNCT01037556Phase 1/2
- Haploidentical Stem Cell Transplantation for Children With Therapy Resistant LeukemiaCompletedNCT01025778Phase 2
- Studying DNA in Blood and Bone Marrow Samples From Young Patients With Acute Lymphoblastic LeukemiaCompletedNCT01016379
- Unrelated Double Umbilical Cord Blood Units TransplantationStatus unknownNCT01015742Phase 2/3
- Allogenic Bone Marrow Transplantation (BMT) Compare With Cytoreduction and Chemotherapy in Acute Lymphoblastic Leukemia (ALL) PatientsCompletedNCT01015261Phase 2/3
- Risk of Psychopathology and Neurocognitive Impairment in Leukemia SurvivorsCompletedNCT01014195
- Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaStatus unknownNCT01005758Phase 2
- Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid LeukemiaCompletedNCT01005277
- First-line Dasatinib Plus Conventional Chemotherapy in Adults With Newly Diagnosed Ph-Positive ALLCompletedNCT01004497Phase 2
- Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic LeukemiaCompletedNCT00995137Phase 1
- Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and LymphomaCompletedNCT00994500Phase 1
- Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic LeukemiaCompletedNCT00993135
- Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)SuspendedNCT00991744Phase 3
- A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL)CompletedNCT00991133Phase 1
- Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic MalignancyCompletedNCT00990587Phase 1
- Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic SyndromeCompletedNCT00988715Phase 1
- Efficacy and Safety of Recombinant Asparaginase in Infants With Previously Untreated Acute Lymphoid Leukemia (ALL)CompletedNCT00983138Phase 2
- Thromboembolic Complications Related to Asparaginase in Children With Acute Lymphoblastic Leukemia (ALL) Treated According to NOPHO ALL 2008Status unknownNCT00982514
- Intraosseous Infusion of Unrelated Cord Blood GraftsTerminatedNCT00967525Not applicable
- Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaCompletedNCT00967057Phase 3
- A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous LeukemiaCompletedNCT00964873Phase 1
- Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological MalignancyTerminatedNCT00963495Phase 1
- Genotyping Analysis of Acute Lymphoblastic LeukemiaStatus unknownNCT00961285
- Haploidentical Stem Cell Transplantation With CD3/CD19 Depletion and Reduced Intensity Conditioning in Patients With Acute LeukemiaTerminatedNCT00961142Phase 2
- Study of Sirolimus With PEG-Asparaginase in Acute Lymphoblastic Leukemia (ALL)WithdrawnNCT00957320Phase 1
- Observational Study of Iron Overload in Stem Cell TransplantationCompletedNCT00954720
- Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma PatientsCompletedNCT00949741
- Assessing the Effectiveness of Individual Education Plans for Childhood Cancer SurvivorsCompletedNCT00945828Not applicable
- PROCEDYTE: Depocyte® Administration (Liposomal Cytarabine) as Prophylaxis of Neuromeningeal Infiltration in Acute Lymphoblastic LeukemiaTerminatedNCT00944008Phase 3
- Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic LeukemiaCompletedNCT00940524Phase 1
- 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With CancerActive, not recruitingNCT00935090
- Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or LeukemiaTerminatedNCT00933985Phase 1
- A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic LeukaemiaCompletedNCT00930098Phase 2
- Pilot Study of Unrelated Cord Blood TransplantationTerminatedNCT00916045Phase 2
- MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic LeukemiaCompletedNCT00911066Phase 1
- Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaTerminatedNCT00905398Phase 1/2
- Physical Activity to Modify Sequelae and Quality of Life in Childhood Acute Lymphoblastic LeukemiaCompletedNCT00902213Not applicable
- Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic LeukemiaWithdrawnNCT00900445
- Studying Fentanyl in Patients With CancerTerminatedNCT00899951
- Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or RemissionCompletedNCT00899899
- DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT00899652
- DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic LeukemiaCompletedNCT00899366
- Collecting and Storing Tissue From Young Patients With CancerCompletedNCT00898755
- Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With MethotrexateCompletedNCT00898404